Efficacy and safety of two dosages of canrenone as add‐on therapy in hypertensive patients taking ace‐inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE‐IT trial
Sign Up to like & getrecommendations! Published in 2017 at "Cardiovascular Therapeutics"
DOI: 10.1111/1755-5922.12235
Abstract: Summary Aim To evaluate the effects of canrenone as add‐on therapy in patients already treated with angiotensin‐converting enzyme inhibitors (ACE‐I) or angiotensin II receptor blockers (ARBs) and hydrochlorothiazide at the maximum dosage (25 mg/d). Method… read more here.
Keywords: canrenone; trial; canrenone add; add therapy ... See more keywords